Search research articles
Contact Us
Filters
Showing results (611-620 of 640) with videos related to
Page
of 64
Sort By:
Annals of Gastroenterology
|
March 23, 2026
Efficacy of current therapeutic strategies for immune checkpoint inhibitor-related esophagitis
Carolina Colli Cruz, Maria Julia M N Santos, Sharada Wali, et al.
Contemporary Clinical Trials
|
February 7, 2018
Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL): Rationale, design and baseline characteristics
Peter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 9, 2026
Independent Testing to Accelerate the Development of Lateral Flow Assays for Influenza A, Influenza B and SARS-COV-2
Anuradha Rao, Laura Johnson, Leda Bassit, et al.
The New England Journal of Medicine
|
September 3, 2020
Weight Loss in Underserved Patients - A Cluster-Randomized Trial
Peter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2022
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Van K Morris, Erin B Kennedy, Nancy N Baxter, et al.
The New England Journal of Medicine
|
October 12, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
Stephen B Kennedy, Fatorma Bolay, Mark Kieh, et al.
Annals of Gastroenterology
|
January 30, 2026
Immune-mediated diarrhea and colitis with normal biochemical, endoscopic and histologic findings: a retrospective study
Malek Shatila, Sharada Wali, Carolina Colli Cruz, et al.
Microbiology Spectrum
|
October 27, 2021
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray
David Camerini, Arlo Z Randall, Krista Trappl-Kimmons, et al.
Trials
|
January 24, 2021
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
Moses Badio, Edouard Lhomme, Mark Kieh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles
C C Chan, S Boyce, C Brideau, et al.
Page
of 64
Search research articles
Search
Showing results (611-620 of 640) with videos related to
Sort By:
Page
of 64
Annals of Gastroenterology
|
March 23, 2026
Efficacy of current therapeutic strategies for immune checkpoint inhibitor-related esophagitis
Carolina Colli Cruz, Maria Julia M N Santos, Sharada Wali, et al.
Contemporary Clinical Trials
|
February 7, 2018
Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL): Rationale, design and baseline characteristics
Peter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 9, 2026
Independent Testing to Accelerate the Development of Lateral Flow Assays for Influenza A, Influenza B and SARS-COV-2
Anuradha Rao, Laura Johnson, Leda Bassit, et al.
The New England Journal of Medicine
|
September 3, 2020
Weight Loss in Underserved Patients - A Cluster-Randomized Trial
Peter T Katzmarzyk, Corby K Martin, Robert L Newton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2022
Treatment of Metastatic Colorectal Cancer: ASCO Guideline
Van K Morris, Erin B Kennedy, Nancy N Baxter, et al.
The New England Journal of Medicine
|
October 12, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
Stephen B Kennedy, Fatorma Bolay, Mark Kieh, et al.
Annals of Gastroenterology
|
January 30, 2026
Immune-mediated diarrhea and colitis with normal biochemical, endoscopic and histologic findings: a retrospective study
Malek Shatila, Sharada Wali, Carolina Colli Cruz, et al.
Microbiology Spectrum
|
October 27, 2021
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray
David Camerini, Arlo Z Randall, Krista Trappl-Kimmons, et al.
Trials
|
January 24, 2021
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
Moses Badio, Edouard Lhomme, Mark Kieh, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 20, 1999
Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles
C C Chan, S Boyce, C Brideau, et al.
Page
of 64